January 2011.... Will MNTA win the lottery this month?
- MNTA receives FDA Approval for mCopaxone - FDA tells Teva probably easier to start over and try again on Lovenox - MNTA share price exceeds $40+ for the first time on the news - MNTA covered call sellers jump out of basement windows over their heartache of not listening to Dew's warnings.